# James P. Lash

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-p-lash/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,999 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 76 |
| i10-index | 256 |
| Last Known Institution | University of Illinois Chicago |
| OpenAlex ID | https://openalex.org/A5058217417 |
| ORCID iD | 0000-0002-6580-4080 |
| Works | 495 |

## Researcher papers

Showing 12 of 14.

- [KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD](https://scholariq.org/papers/kdoqi-us-commentary-on-the-2012-kdigo-clinical-practice-guideline-for-the/)
- [Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease](https://scholariq.org/papers/fibroblast-growth-factor-23-is-elevated-before-parathyroid-hormone-and-phosphate/)
- [Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US](https://scholariq.org/papers/factors-associated-with-death-in-critically-ill-patients-with-coronavirus/)
- [Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection](https://scholariq.org/papers/development-of-a-definition-of-postacute-sequelae-of-sars-cov-2-infection/)
- [<i>APOL1</i> Risk Variants, Race, and Progression of Chronic Kidney Disease](https://scholariq.org/papers/i-apol1-i-risk-variants-race-and-progression-of-chronic-kidney-disease/)
- [Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease](https://scholariq.org/papers/intensive-blood-pressure-control-in-hypertensive-chronic-kidney-disease/)
- [The Chronic Renal Insufficiency Cohort (CRIC) Study](https://scholariq.org/papers/the-chronic-renal-insufficiency-cohort-cric-study/)
- [Chronic Renal Insufficiency Cohort (CRIC) Study](https://scholariq.org/papers/chronic-renal-insufficiency-cohort-cric-study/)
- [Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19](https://scholariq.org/papers/association-between-early-treatment-with-tocilizumab-and-mortality-among/)
- [Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)](https://scholariq.org/papers/chronic-kidney-disease-and-prevalent-atrial-fibrillation-the-chronic-renal/)
- [Fibroblast Growth Factor-23 and Cardiovascular Events in CKD](https://scholariq.org/papers/fibroblast-growth-factor-23-and-cardiovascular-events-in-ckd/)
- [Fibroblast growth factor 23 is not associated with and does not induce arterial calcification](https://scholariq.org/papers/fibroblast-growth-factor-23-is-not-associated-with-and-does-not-induce-arterial/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Health and Risk Factors](https://scholariq.org/topics/cardiovascular-health-and-risk-factors/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)

## Researcher university

- [University of Illinois Chicago](https://scholariq.org/institutions/university-of-illinois-chicago/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.